The best-characterized agents are anti-CD47 antibodies, which have proven effective in inducing phagocytosis of cancer cells in vitro as well as inhibiting tumor growth in murine models of both hematologic and solid tumors [75,78]. This evidence concerns the gene CD47 and neoplasm.